Financial Network Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Financial Network Wealth Advisors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.32K	Buy	20 +6	+43%	+$1.41K	0.01%	541
2026 Q1	$2.79K	Hold	14	–	–	﹤0.01%	618
2025 Q4	$2.65K	Sell	14 -10	-42%	-$1.92K	﹤0.01%	627
2025 Q3	$4.25K	Hold	24	–	–	﹤0.01%	545
2025 Q2	$2.73K	Sell	24 -1	-4%	-$107	﹤0.01%	595
2025 Q1	$2.63K	Buy	+25	New	+$2.83K	﹤0.01%	555
2024 Q4	–	Sell	-25	Closed	-$2.5K	–	682
2024 Q3	$2.5K	Buy	25 +4	+19%	+$403	﹤0.01%	607
2024 Q2	$1.77K	Buy	+21	New	+$1.67K	﹤0.01%	760

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Network Wealth Advisors's LGND Position: Q2 2026 in Review

Financial Network Wealth Advisors increased its Ligand Pharmaceuticals (LGND) stake by 43% in Q2 2026, buying an estimated $1.41K and bringing the position to 20 shares worth $6.32K. The position accounts for 0.01% of the portfolio, ranked #541.

Financial Network Wealth Advisors first reported a position in LGND in Q2 2024 and has held it in 8 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Financial Network Wealth Advisors held 20 shares of Ligand Pharmaceuticals worth $6.32K as of Q2 2026.
Financial Network Wealth Advisors bought 6 Ligand Pharmaceuticals shares in Q2 2026, an estimated $1.41K.
Ligand Pharmaceuticals made up 0.01% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #541 holding.
Financial Network Wealth Advisors first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.